Distal esophageal reflux accompanies nocturnal gastric acid breakthrough in patients with gastroesophageal reflux disease (GERD) on proton pump inhibitor (PPI) bid.

被引：3
|
作者：
Anderson, C [1 ]
Katz, P [1 ]
Khoury, R [1 ]
Castell, D [1 ]
机构：
[1] Allegheny Univ Hosp, Philadelphia, PA USA
来源：
GASTROENTEROLOGY | 1998年 / 114卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(98)80229-1
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
G0229
引用
收藏
页码：A56 / A57
页数：2
相关论文
共 50 条
  • [1] Nocturnal gastric acid breakthrough is not useful in predicting pathologic nocturnal esophageal reflux in patients with GERD treated with a proton pump inhibitor
    Gardner, JD
    Sloan, S
    Robinson, M
    Miner, PB
    [J]. GASTROENTEROLOGY, 2005, 128 (04) : A525 - A525
  • [2] Nocturnal gastroesophageal reflux (GER) is associated with gastric acid breakthrough to pH <2 on proton pump inhibitors twice daily (PPI BID)
    Fouad, YM
    Katz, PO
    Maldonado, A
    Hammod, R
    Castell, DO
    [J]. GASTROENTEROLOGY, 1999, 116 (04) : A208 - A208
  • [3] Evaluation of Proton-Pump-Inhibitor (PPI) -Resistant Gastroesophageal Reflux Disease (GERD) By Esophageal Motility Tests
    Kawaguchi, Shinpei
    Takeuchi, Toshihisa
    Takahashi, Yoshiaki
    Harada, Satoshi
    Ota, Kazuhiro
    Kojima, Yuichi
    Higuchi, Kazuhide
    [J]. GASTROINTESTINAL ENDOSCOPY, 2016, 83 (05) : AB586 - AB586
  • [4] PREDICTORS OF PROTON PUMP INHIBITOR (PPI) DOSING REGIMEN AMONG PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE (GERD)
    Eisenberg, D.
    Mody, R.
    Singer, J.
    Kamat, S. A.
    Gerson, L. B.
    [J]. VALUE IN HEALTH, 2011, 14 (03) : A180 - A180
  • [5] Laryngopharyngeal reflux disease with nocturnal gastric acid breakthrough while on proton pump inhibitor therapy
    Sato, Kiminori
    [J]. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2006, 263 (12) : 1121 - 1126
  • [6] Laryngopharyngeal reflux disease with nocturnal gastric acid breakthrough while on proton pump inhibitor therapy
    Kiminori Sato
    [J]. European Archives of Oto-Rhino-Laryngology and Head & Neck, 2006, 263 : 1121 - 1126
  • [7] Nocturnal Gastric Acid Breakthrough Is Not Associated with Night-Time Gastroesophageal Reflux in GERD Patients
    Weigt, Jochen
    Kandulski, Arne
    Buesch, Franziska
    Malfertheiner, Peter
    [J]. DIGESTIVE DISEASES, 2009, 27 (01) : 68 - 73
  • [8] The impact of a formulary change in proton pump inhibitor(PPI)as maintenance treatment for gastroesophageal reflux disease(GERD).
    Schaberg, JW
    Chockalingam, SK
    Mah'moud, MA
    Moloo, J
    Ugheoke, EA
    Vasudeva, R
    [J]. GASTROENTEROLOGY, 1999, 116 (04) : A93 - A93
  • [9] ARBACLOFEN PLACARBIL IMPROVES SLEEP QUALITY IN PATIENTS WITH PROTON PUMP INHIBITOR (PPI)-RESPONSIVE GASTROESOPHAGEAL REFLUX DISEASE (GERD)
    Fass, R.
    Vakil, N.
    Huff, F.
    Jones, D.
    Bian, A.
    Stamler, D.
    [J]. SLEEP, 2010, 33 : A291 - A292
  • [10] The Value of Upper Endoscopy in Patients with Gastroesophageal Reflux Disease (GERD) Who Failed Proton Pump Inhibitor (PPI) Therapy
    Van Handal, Dan
    Hussain, Feroze
    Bhatt, Rajan
    Dickman, Ram
    Hernandez, Diley
    Fass, Ronnie
    [J]. GASTROINTESTINAL ENDOSCOPY, 2006, 63 (05) : AB139 - AB139
12345